Catherine Tananis Anthony
Vanderbilt University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Catherine Tananis Anthony.
Annals of the New York Academy of Sciences | 1991
Michael K. Skinner; John N. Norton; Brian P. Mullaney; Marinella Rosselli; Patricia D. Whaley; Catherine Tananis Anthony
Regulatory interactions have been shown to occur between all the testicular cell types considered. The paracrine factors mediating these interactions generally influence either cellular growth or differentiation. The regulation of cellular growth is essential in the developing testis and is required for the maintenance of spermatogenesis in the adult testis. The rapid rate of germinal cell proliferation and the continuous but slowed growth of the peritubular cells and Leydig cells requires the presence of specific growth factors in the adult. Therefore, cell-cell interactions have evolved that involve growth factors such as IGF, TGF-alpha, TGF-beta and NGF. Other growth factors such as FGF or less characterized components like the seminiferous growth factor (SGF) also may be involved in the paracrine regulation of testis cell growth. An alternate cellular parameter to cell growth to consider is the regulation of cellular function and differentiation. A number of endocrine agents and locally produced paracrine factors have been shown to control and maintain testis cell function and differentiation. Cell-cell interactions mediated by factors such as androgens, POMC peptides, and PModS are all primarily directed at the regulation of cellular differentiation. Therefore, the agents which mediate cell-cell interactions in the testis can generally be categorized into factors that regulate cell growth or those which influence cellular differentiation. The specific cell-cell interactions identified will likely be the first of a large number of cellular interactions yet to be investigated. Although a number of potentially important cell-cell interactions have been identified, future research will require the elucidation of the in vivo physiological significance of these interactions. The existence of different cell types and potential cell-cell interactions in a tissue implies that the actions of an endocrine agent on a tissue will not simply involve a single hormone and single cell. The endocrine regulation of testis function will have effects on cell-cell interactions and be affected by local cell-cell interactions. The ability of LH to influence Leydig cell androgen production promotes a cascade of interactions mediated through several cell types to maintain the process of spermatogenesis. FSH actions on Sertoli cells also promote cell-cell interactions that influence germinal cell development, peritubular myoid cell differentiation and Leydig cell function. Therefore, elucidation of the endocrine regulation of testis function requires an understanding of the local cell-cell interactions in the testis.
Urology | 1997
Kent T. Perry; Catherine Tananis Anthony; Tom Case; Mitchell S. Steiner
OBJECTIVES Tumor biomarkers to detect prostate cancer earlier may reduce prostate cancer deaths. Transforming growth factor-beta1 and -beta2 (TGF-beta1 and -beta2) become overexpressed in prostate cancer and might be useful tumor markers of prostate cancer. METHODS Plasma and urinary TGF-beta1 and plasma TGF-beta2 levels were studied preoperatively in 74 consecutive patients who had prostate cancer and underwent radical prostatectomy and were compared with those of 29 similarly aged male control patients who had no clinical evidence of prostate cancer. RESULTS Plasma TGF-beta1 levels were similar in both prostate cancer and control groups and did not correlate with serum prostate-specific antigen (PSA), clinical and pathologic stages, or Gleason grade. Urinary TGF-beta1 levels, however, increased 3.5-fold in patients with prostate cancer relative to controls and tended to be higher with advancing clinical and pathologic stages. Plasma TGF-beta2 levels, like plasma TGF-beta1 levels, were similar for both the study and control groups, but when stratified by pathologic stage or Gleason grade, patients with prostate cancer with pathologic Stage T2a and Gleason grade of 3 or less had significantly increased plasma TGF-beta2 levels as compared with either control patients or patients with prostate cancer with pathologic Stages T2b/T2c and T3/T4 or Gleason grade of 4 or more, suggesting that early prostate cancer may contribute to plasma TGF-beta2 levels. CONCLUSIONS Unlike plasma TGF-beta1 levels, urinary TGF-beta1 and plasma TGF-beta2 levels were higher in patients with prostate cancer and may be useful biomarkers of prostate cancer.
The Prostate | 1997
Kent T. Perry; Catherine Tananis Anthony; Mitchell S. Steiner
Prostate cancer eventually becomes androgen‐independent, suggesting that growth factors such as TGFβ1–3 may potentially contribute to prostate neoplasia. The pattern and level of TGFβ1–3 protein expression in normal and malignant human prostate are unknown.
Molecular and Cellular Endocrinology | 1989
Michael K. Skinner; Barbara Stallard; Catherine Tananis Anthony; Michael D. Griswold
The cellular location of fibronectin expression within the seminiferous tubule was investigated in order to better understand testicular cell functions and cell-cell interactions. Peritubular cells were shown to actively synthesize and secrete fibronectin in culture by the detection of a radiolabeled 220 kDa secreted protein that is immunologically similar to fibronectin and by the quantitation of fibronectin in peritubular cell conditioned medium with a fibronectin enzyme-linked immunosorbent assay. Sertoli cells did not produce detectable levels of fibronectin when assayed by either of these procedures. A 6.5 kb fibronectin messenger RNA was detected in freshly isolated or cultured peritubular cells, but no fibronectin gene expression was detected in Sertoli cells or developing germinal cells. Combined results imply that the peritubular cells are the only apparent site of fibronectin expression within the seminiferous tubule. During the development of the testis the levels of fibronectin expression increased to a maximum at early puberty (15-day-old rats) and then slowly declined. The results demonstrate that fibronectin can be utilized as a unique functional and biochemical marker for peritubular cells when compared to other cell types in the seminiferous tubule. Production of fibronectin by peritubular cells provides an example of the ability of peritubular cells and Sertoli cells to cooperate in the production of individual components of the basement membrane of the seminiferous tubule. This cellular interaction is an example of a mesenchymal/stromal-epithelial interaction which is postulated to be important for the physiology of many tissues.
Archive | 1992
John N. Norton; Catherine Tananis Anthony; Michael K. Skinner
Follicle stimulating hormone (FSH) is a gonadotropin secreted from the pituitary that influences the function and differentiation of the testicular Sertoli cell (Sc). This influence of FSH on Sc is mediated through activation of adenylate cyclase, followed by elevation of cAMP levels, stimulation of cAMP-dependent protein kinase, and regulation of gene expression (1–5). FSH promotes and regulates Sc function and differentiation throughout pubertal development; however, the role of FSH in the adult animal is unclear and remains to be fully elucidated.
Journal of Biological Chemistry | 1988
Michael K. Skinner; P M Fetterolf; Catherine Tananis Anthony
Human Gene Therapy | 1998
Mitchell S. Steiner; Catherine Tananis Anthony; Yi Lu; Jeffrey T. Holt
Endocrinology | 1989
Michael K. Skinner; Susan M. Schlitz; Catherine Tananis Anthony
Biology of Reproduction | 1989
Catherine Tananis Anthony; Michael K. Skinner
Endocrinology | 1989
Catherine Tananis Anthony; William J. Kovacs; Michael K. Skinner